Information for Public Companies That Would Like to Participate in Spotlight Panel Discussions

Mid-, small – and micro-cap companies in the following categories are invited to apply to participate at BioFuture:

• Small/large molecule R&D therapeutic
• Platform
• Tool
• Delivery
• Molecular diagnostic and personalized medicine
• Research focused service providers
• Digital Medicine
• Artificial Intelligence (AI)

BioFuture Public Company Fees

• Public company participation fee:
  • $2,750 Super Early Bird Registration Fee (Ends August 18)
  • $2,950 Early Bird Registration Fee (Ends September 15)
  • $3,150 Regular Registration Fee (Ends October 13)
  • $3,350 Onsite Registration Fee
• This fee includes access for one (1) presenter, and one (1) company employee